3.0.0 5568 2023-01-11T13:39:49Z 2023-01-11T13:39:49Z House HR 2018-04-18 115 [Congressional Record Volume 164, Number 63 (Wednesday, April 18, 2018)]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. PALLONE:H.R. 5568.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8, clause 3 of the U.S. Constitution.That provision gives Congress the power ``to regulatecommerce with foreign nations, and among the several states,and with the Indian tribes.''[Page H3443]]]> hsif00 Energy and Commerce Committee House Standing Referred to 2018-04-18T14:04:10Z 2018-04-18 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2018-04-18 Introduced in House IntroReferral Intro-H 9 Library of Congress 2018-04-18 Introduced in House IntroReferral 1000 9 Library of Congress P000034 Rep. Pallone, Frank, Jr. [D-NJ-6] FRANK PALLONE D NJ 6 N G000558 Rep. Guthrie, Brett [R-KY-2] Brett Guthrie R KY 2 2018-04-18 True Health Advanced technology and technological innovations Congressional oversight Drug safety, medical device, and laboratory regulation Educational facilities and institutions Government information and archives Health programs administration and funding Health technology, devices, supplies Higher education Manufacturing Prescription drugs Product development and innovation Research administration and funding Research and development Health 00 2018-04-18 Introduced in House 2019-08-20T17:20:10Z National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018

This bill authorizes the Food and Drug Administration to partner with institutions of higher education to designate them as National Centers of Excellence in Continuous Pharmaceutical Manufacturing for the purpose of studying and recommending improvements to the process of continuous manufacturing of medications. (Currently, most medications are manufactured in batches.)

]]> National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018 Display Title National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018 Official Title as Introduced To amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes. Introduced in House IH Short Titles as Introduced National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018 Introduced in House 2018-04-18T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-115hr5568ih/xml/BILLS-115hr5568ih.xml 2018-04-18 Referred to the House Committee on Energy and Commerce. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.